Vascular remodeling in cancer. (Q38126351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Vascular remodeling in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

microvasculature remodeling

6 March 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Steven A Stacker

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

R H Farnsworth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Lackmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

5 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

3496-3505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912450%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Molecular regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The lymphatic vasculature in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Focus on lymphangiogenesis in tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Targeting lymphangiogenesis to prevent tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Hijacking the vasculature in ccRCC--co-option, remodelling and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Preservation of Vascular Integrity in Organs perfused in vitro with a Platelet-rich Medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS : I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Endothelial/pericyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Endothelial cell heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Causes and consequences of tumour acidity and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Biological consequences of tumor hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Hypoxia-driven selection of the metastatic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Heterogeneity of the tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Comparative Evaluation of FGF-2–, VEGF-A–, and VEGF-C–Induced Angiogenesis, Lymphangiogenesis, Vascular Fenestrations, and Permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Molecular diversity of VEGF-A as a regulator of its biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The prognostic role of vessel productive changes and vessel density in oligodendroglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Histology far away from Flatland: 3D roller-coasting into grade-dependent angiogenetic patterns in oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Anti-angiogenesis: making the tumor vulnerable to the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Prognostic and predictive impact of intra- and peritumoral immune infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Molecular control of lymphatic metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Do all roads lead to Rome? Routes to metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Genes that distinguish physiological and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Lymphatic zip codes in premalignant lesions and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Pericytes and vessel maturation during tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Pericytes: gatekeepers in tumour cell metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The role of myeloid cells in the promotion of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Migratory neighbors and distant invaders: tumor-associated niche cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

DC ablation in mice: promises, pitfalls, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor-host interactions: a far-reaching relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Involvement of endothelial progenitor cells in tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Contribution of bone marrow–derived endothelial cells to human tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

CD133+ renal progenitor cells contribute to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Endothelial cell differentiation of human breast tumour stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor origin of endothelial cells in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Precancerous stem cells can serve as tumor vasculogenic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Stem-like ovarian cancer cells can serve as tumor vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The role of endothelial-to-mesenchymal transition in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

From tumor lymphangiogenesis to lymphvascular niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Prospects for vasculature reorganization in sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumour-induced immune modulation of sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Synchrony of high endothelial venules and lymphatic vessels revealed by immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Neogenesis and development of the high endothelial venules that mediate lymphocyte trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Lymphangiogenesis in Regional Lymph Nodes Is an Independent Prognostic Marker in Rectal Cancer Patients after Neoadjuvant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Innate control of adaptive immunity via remodeling of lymph node feed arteriole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Preparing the "soil": the premetastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Association of Angiogenesis in Lymph Node Metastases With Outcome of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

A Novel Gene Expression Profile in Lymphatics Associated with Tumor Growth and Nodal Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Identification of a tumor-initiating stem cell population in human renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Vascular permeability factor, an endothelial cell mitogen related to PDGF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Permeability properties of tumor surrogate blood vessels induced by VEGF-A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Priming of naive T cells inside tumors leads to eradication of established tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Origin of endothelial progenitors in human postnatal bone marrow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Lymphatic vessels and high endothelial venules are increased in the sentinel lymph nodes of patients with oral squamous cell carcinoma before the arrival of tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304

Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.304